Company Filing History:
Years Active: 1993-1994
Title: Yasushi Shikata: Innovator in Antitumor Research
Introduction
Yasushi Shikata is a notable inventor based in Ibaraki, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of antitumor agents. With a total of 2 patents to his name, Shikata's work is recognized for its potential impact on cancer treatment.
Latest Patents
Shikata's latest patents focus on a recombinant natural killer cell activator. This invention discloses a recombinant natural killer cell activating factor, preferably characterized by a specific peptide sequence. The invention includes a cDNA coding for this factor, an expression plasmid involving the cDNA, and a host transformed with the plasmid. Additionally, it encompasses an antitumor agent containing the recombinant natural killer cell activating factor and a pharmaceutical composition that comprises a pharmacologically effective amount of the antitumor agent along with a pharmacologically acceptable carrier.
Career Highlights
Yasushi Shikata is currently associated with Eisai Company, Limited, where he continues to advance his research in biotechnology. His work is pivotal in the development of innovative therapies aimed at combating cancer.
Collaborations
Shikata has collaborated with notable colleagues, including Kentaro Yoshimatsu and Yukio Ohya. These partnerships have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Yasushi Shikata's contributions to the field of biotechnology, particularly in antitumor research, highlight his role as an influential inventor. His innovative work continues to pave the way for new therapeutic options in cancer treatment.